Cargando…
Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations
PURPOSE: Extrinsic factors and genetic predisposition contribute to the etiology of sarcoidosis, converging in a phenotype of altered immune response associated with multisystemic inflammatory granulomatous tissue infiltration. Immunological reconstitution after hematopoietic stem cell transplantati...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529157/ https://www.ncbi.nlm.nih.gov/pubmed/34691055 http://dx.doi.org/10.3389/fimmu.2021.746996 |
_version_ | 1784586408691761152 |
---|---|
author | Wurm-Kuczera, Rebecca Isabel Buentzel, Judith Koenig, Julia Felicitas Leni Legler, Tobias Valk, Jan-Jakob Hasenkamp, Justin Jung, Wolfram Rademacher, Jan-Gerd Korsten, Peter Wulf, Gerald Georg |
author_facet | Wurm-Kuczera, Rebecca Isabel Buentzel, Judith Koenig, Julia Felicitas Leni Legler, Tobias Valk, Jan-Jakob Hasenkamp, Justin Jung, Wolfram Rademacher, Jan-Gerd Korsten, Peter Wulf, Gerald Georg |
author_sort | Wurm-Kuczera, Rebecca Isabel |
collection | PubMed |
description | PURPOSE: Extrinsic factors and genetic predisposition contribute to the etiology of sarcoidosis, converging in a phenotype of altered immune response associated with multisystemic inflammatory granulomatous tissue infiltration. Immunological reconstitution after hematopoietic stem cell transplantation (HSCT) may represent a unique window for the pathogenesis of the disease. We describe the incidence, clinicopathological features, and HLA associations of sarcoidosis after HSCT in a single-center cohort of patients, together with data from previously published cases. METHODS: We retrospectively analyzed clinical characteristics and HLA haplotypes from allogeneic (allo) or autologous (auto) HSCT patients from January 2001 through May 2021 at the University Medicine Goettingen (UMG), and data from previously published cases. RESULTS: A total number of 19 patients was identified. These included 4 patients from our center (3 allo HSCT and 1 auto HSCT) and 15 patients from the literature review. Thirteen patients had received an allo HSCT, and six patients had received an auto HSCT. Sarcoidosis occurred after a median interval of 20 (after allo HSCT) and 7 (after auto HSCT) months, respectively. The predominant HLA allele associated with sarcoidosis was HLA DRB1*03:01. Sarcoidosis involved the respiratory tract in 15 patients (three unknown, one without pulmonary involvement), and it was associated with graft-versus-host disease in 7 of 13 patients receiving allo HSCT. None of the donors or patients had a history of sarcoidosis before transplantation. Disease manifestations resolved with standard glucocorticoid treatment without long-term sequelae. CONCLUSION: Sarcoidosis may occur at low frequency during reconstitution of the immune system after HSCT. HLA allele associations reflect the associations observed in the general population, particularly with DRB1*03:01. Further insights into the interplay between Tcell reconstitution and the development of sarcoidosis could also provide novel approaches to an improved understanding of the pathogenesis in sarcoidosis. |
format | Online Article Text |
id | pubmed-8529157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85291572021-10-22 Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations Wurm-Kuczera, Rebecca Isabel Buentzel, Judith Koenig, Julia Felicitas Leni Legler, Tobias Valk, Jan-Jakob Hasenkamp, Justin Jung, Wolfram Rademacher, Jan-Gerd Korsten, Peter Wulf, Gerald Georg Front Immunol Immunology PURPOSE: Extrinsic factors and genetic predisposition contribute to the etiology of sarcoidosis, converging in a phenotype of altered immune response associated with multisystemic inflammatory granulomatous tissue infiltration. Immunological reconstitution after hematopoietic stem cell transplantation (HSCT) may represent a unique window for the pathogenesis of the disease. We describe the incidence, clinicopathological features, and HLA associations of sarcoidosis after HSCT in a single-center cohort of patients, together with data from previously published cases. METHODS: We retrospectively analyzed clinical characteristics and HLA haplotypes from allogeneic (allo) or autologous (auto) HSCT patients from January 2001 through May 2021 at the University Medicine Goettingen (UMG), and data from previously published cases. RESULTS: A total number of 19 patients was identified. These included 4 patients from our center (3 allo HSCT and 1 auto HSCT) and 15 patients from the literature review. Thirteen patients had received an allo HSCT, and six patients had received an auto HSCT. Sarcoidosis occurred after a median interval of 20 (after allo HSCT) and 7 (after auto HSCT) months, respectively. The predominant HLA allele associated with sarcoidosis was HLA DRB1*03:01. Sarcoidosis involved the respiratory tract in 15 patients (three unknown, one without pulmonary involvement), and it was associated with graft-versus-host disease in 7 of 13 patients receiving allo HSCT. None of the donors or patients had a history of sarcoidosis before transplantation. Disease manifestations resolved with standard glucocorticoid treatment without long-term sequelae. CONCLUSION: Sarcoidosis may occur at low frequency during reconstitution of the immune system after HSCT. HLA allele associations reflect the associations observed in the general population, particularly with DRB1*03:01. Further insights into the interplay between Tcell reconstitution and the development of sarcoidosis could also provide novel approaches to an improved understanding of the pathogenesis in sarcoidosis. Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8529157/ /pubmed/34691055 http://dx.doi.org/10.3389/fimmu.2021.746996 Text en Copyright © 2021 Wurm-Kuczera, Buentzel, Koenig, Legler, Valk, Hasenkamp, Jung, Rademacher, Korsten and Wulf https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Wurm-Kuczera, Rebecca Isabel Buentzel, Judith Koenig, Julia Felicitas Leni Legler, Tobias Valk, Jan-Jakob Hasenkamp, Justin Jung, Wolfram Rademacher, Jan-Gerd Korsten, Peter Wulf, Gerald Georg Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations |
title | Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations |
title_full | Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations |
title_fullStr | Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations |
title_full_unstemmed | Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations |
title_short | Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations |
title_sort | sarcoidosis following hematopoietic stem cell transplantation: clinical characteristics and hla associations |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529157/ https://www.ncbi.nlm.nih.gov/pubmed/34691055 http://dx.doi.org/10.3389/fimmu.2021.746996 |
work_keys_str_mv | AT wurmkuczerarebeccaisabel sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations AT buentzeljudith sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations AT koenigjuliafelicitasleni sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations AT leglertobias sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations AT valkjanjakob sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations AT hasenkampjustin sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations AT jungwolfram sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations AT rademacherjangerd sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations AT korstenpeter sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations AT wulfgeraldgeorg sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations |